Tech Company Financing Transactions
Journey Clinical Funding Round
Union Square Ventures, Able Partners and AlleyCorp participated in a $8.5 million Series A funding round for Journey Clinical. The round was announced on 1/24/2023.
Transaction Overview
Company Name
Announced On
1/24/2023
Transaction Type
Venture Equity
Amount
$8,500,000
Round
Series A
Investors
Proceeds Purpose
Companies focused on psychedelic treatment.
Company Information
Company Status
Private & Independent
Industry
Healthcare Services
Mailing Address
305 Second Avenue Apartment 511
New York, NY 10003
USA
New York, NY 10003
USA
Phone
Undisclosed
Website
Email Address
Overview
Journey Clinical is on a mission to transform the growing mental health crisis by accelerating the adoption of frontier treatments that lead to lasting improvements in clinical outcomes. We have built a turnkey healthtech platform to safely and effectively expand access to a powerful modality known as Psychedelic-Assisted Psychotherapy, starting with Ketamine-Assisted Psychotherapy (KAP). In our patient-centered collaborative care model, licensed psychotherapists in the network take on the psychotherapy, while Journey Clinical's in-house medical team takes on patient eligibility, treatment plan and outcome monitoring.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Jonathan Sabbagh
Chief Operating Officer
Myriam Barthes
Browse more venture capital transactions:
Prev: 1/24/2023: KEWAZO venture capital transaction
Next: 1/24/2023: Osmo venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on all VC transactions involving tech companies. VC investment data records on this site are derived from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs